We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
576
CALL
Iovance Biotherapeutics
IOVA
$2.83B
-40,000
Closed -$20K
IP icon
577
International Paper
IP
$22B
-53,760
Closed -$2.1M
IWM icon
578
CALL
iShares Russell 2000 ETF
IWM
$83B
-30,000
Closed -$205K
KPTI icon
579
CALL
Karyopharm Therapeutics
KPTI
$48M
-21,720
Closed -$33.9K
KRYS icon
580
CALL
Krystal Biotech
KRYS
$9.66B
-12,000
Closed -$133K
LAMR icon
581
Lamar Advertising Co
LAMR
$16.3B
-1,775
Closed -$212K
LEGN icon
582
CALL
Legend Biotech
LEGN
$4.01B
-30,000
Closed -$18.5K
LRMR icon
583
CALL
Larimar Therapeutics
LRMR
$432M
-40,000
Closed -$2K
M icon
584
PUT
Macy's
M
$6.68B
-60,000
Closed -$60K
MAC icon
585
Macerich
MAC
$6.92B
-145,775
Closed -$2.51M
MAT icon
586
CALL
Mattel
MAT
$4.3B
-172,500
Closed -$62.3K
MCD icon
587
McDonald's
MCD
$195B
-7,500
Closed -$2.11M
MCHP icon
588
Microchip Technology
MCHP
$46B
-10,000
Closed -$897K
MDT icon
589
Medtronic
MDT
$112B
-16,702
Closed -$1.46M
MRUS
590
PUT
DELISTED
Merus
MRUS
-20,000
Closed -$50K
NHI icon
591
National Health Investors
NHI
$3.65B
-6,775
Closed -$426K
NKTX icon
592
Nkarta
NKTX
$172M
-80,000
Closed -$865K
NLY icon
593
Annaly Capital Management
NLY
$17.4B
-96,500
Closed -$1.9M
NOW icon
594
ServiceNow
NOW
$129B
-10,595
Closed -$1.62M
NSC icon
595
Norfolk Southern
NSC
$75.1B
-69,500
Closed -$17.7M
NTES icon
596
NetEase
NTES
$84.7B
-19,058
Closed -$1.97M
NVCR icon
597
CALL
NovoCure
NVCR
$1.91B
-100,000
Closed -$120K
NVCR icon
598
NovoCure
NVCR
$1.91B
-22,782
Closed -$356K
NXRT
599
NexPoint Residential Trust
NXRT
$652M
-33,550
Closed -$1.08M
OCUL icon
600
CALL
Ocular Therapeutix
OCUL
$2.02B
-50,000
Closed -$8.75K

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.